Vitamin D Council needs your help...

Tax-deductible!

Together we can end the illness and disease caused by the worldwide epidemic of vitamin D deficiency.

About Vitamin D Council

Contact Vitamin D Council

Sponsor Vitamin D Council

Follow us on:

Vitamin D Products

(off-site)

These companies donate to the Vitamin D Council.

D-Lite, Renew, & SunSplash UV/Tanning Systems
In-Home ZRT Vitamin D Blood Test Kit
Get Premium Quality Vitamin D Supplements at Great Prices
Vitamin D3 Plus™ from Bio-Tech — contains the cofactors Vitamin D needs to work properly.

Vitamin D Research

back to research menu

Mineral Metabolism

Human duodenum responses to vitamin D metabolites of TRPV6 and other genes involved in calcium absorption. Am J Physiol Gastrointest Liver Physiol. 2009 Sep 24.
Treating mineral metabolism disorders in patients undergoing long hemodialysis: A search for an optimal strategy. Hemodial Int. 2009 Sep 16.
Bone mineral density and disorders of mineral metabolism in chronic liver disease. World J Gastroenterol. 2009 Jul 28;15(28):3516–22.
Is replacement therapy with nutritional and active forms of vitamin D required in chronic kidney disease mineral and bone disorder? Curr Opin Nephrol Hypertens. 2009 Jul;18(4):308–14.
Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation. 2009 Jun 2;119(21):2765–71.
Effects of 3,3',4,4',5-pentachlorobiphenyl (PCB126) on vertebral bone mineralization and on thyroxin and vitamin D levels in Sprague-Dawley rats. Toxicol Lett. 2009 Jun 1;187(2):63–8.
Existing and potentially novel functional markers of vitamin D status: a systematic review. Am J Clin Nutr. 2009 Jun;89(6):1997S–2008S. Review.
Association between Plasma 25-Hydroxyvitamin D and Breast Cancer Risk. Cancer Prev Res (Phila Pa). 2009 Jun;2(6):598–604.
Reversal of mineral ion homeostasis and soft-tissue calcification of klotho knockout mice by deletion of vitamin D 1alpha-hydroxylase. Kidney Int. 2009 Jun;75(11):1166–72.
Regulation of human vitamin D(3) 25-hydroxylases in dermal fibroblasts and prostate cancer LNCaP cells. Mol Pharmacol. 2009 Jun;75(6):1392–9.
Endocrine and musculoskeletal abnormalities in patients with Down syndrome. Nat Rev Endocrinol. 2009 Jun;5(6):327–34.
Is replacement therapy with nutritional and active forms of vitamin D required in chronic kidney disease mineral and bone disorder? Curr Opin Nephrol Hypertens. 2009 May 19.
The importance of inflammation and vitamin D status in SLE-associated osteoporosis. Autoimmun Rev. 2009 May 7.
Dehydroepiandrosterone replacement therapy in older adults: 1- and 2-y effects on bone. Am J Clin Nutr. 2009 May;89(5):1459–67.
Low vitamin D status has an adverse influence on bone mass, bone turnover, and muscle strength in Chinese adolescent girls. J Nutr. 2009 May;139(5):1002–7.
Cinacalcet and achievement of the NKF/K-DOQITM recommended target values for bone and mineral metabolism in real-world clinical practice—the ECHO observational study. Nephrol Dial Transplant. 2009 Apr 15.
Vitamin D metabolism impairment in the rat's offspring following maternal exposure to 137cesium. Arch Toxicol. 2009 Apr;83(4):357–62.
Intestinal vitamin D receptor is required for normal calcium and bone metabolism in mice. Gastroenterology. 2009 Apr;136(4):1317–27, e1–2.
Calcium and Phosphorus Homeostasis. Blood Purif. 2009 Mar 23;27(4):387–394.
Vitamin D metabolism and vitamin D traditional and nontraditional, target organs: implications for kidney patients. J Ren Care. 2009 Mar;35 Suppl 1:39–44.
Rheumatic manifestations of renal disease. Curr Opin Rheumatol. 2009 Jan;21(1):55–61. Review.
The vitamin D deficiency pandemic and consequences for nonskeletal health: Mechanisms of action. Mol Aspects Med. 2008 Dec;29(6):361–8. Review.
Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers. Nephrol Dial Transplant. 2008 Nov;23(11):3670–6.
Phospho-soda-induced symptomatic hypocalcemia in a patient with cystic fibrosis and vitamin D malabsorption. J Pediatr Gastroenterol Nutr. 2008 Oct;47(4):514–6.
Percent true calcium absorption, mineral metabolism, and bone mineralization in children with cystic fibrosis: effect of supplementation with vitamin D and calcium. Pediatr Pulmonol. 2008 Aug;43(8):772–80.
Calcium channel TRPV6 is involved in murine maternal-fetal calcium transport. J Bone Miner Res. 2008 Aug;23(8):1249–56.
Vitamin D receptor activators can protect against vascular calcification. J Am Soc Nephrol. 2008 Aug;19(8):1509–19.
Salmon calcitonin in prevention of osteoporosis in maintenance dialysis patients. Chin Med J (Engl). 2008 Jul 20;121(14):1280–4.
The remodeling transient and the calcium economy. Osteoporos Int. 2008 Jul;19(7):1001–9.
Vitamin D and anti-aging medicine. Clin Calcium. 2008 Jul;18(7):980–5. Review.
Secondary osteoporosis in long-term bedridden patients with cerebral palsy. Pediatr Int. 2008 Jun;50(3):269–75.
Mineral metabolism and bone abnormalities in children with chronic renal failure. Rev Endocr Metab Disord. 2008 Jun;9(2):131–7. Review.
Enriched uranium affects the expression of vitamin D receptor and retinoid X receptor in rat kidney. J Steroid Biochem Mol Biol. 2008 Jun;110(3–5):263–8.
Effects of antiosteoporotic agents on glucose and lipid metabolism and cardiovascular system. Clin Calcium. 2008 May;18(5):677–84. Review in Japanese.
Generalized metabolic bone disease in Neurofibromatosis type I. Mol Genet Metab. 2008 May;94(1):105–11.
Healthy children with frequent fractures: how much evaluation is needed? Pediatrics. 2008 May;121(5):890–7.
Vitamin D insufficiency underlies unexpected hypocalcemia following high dose glucocorticoid therapy. Bone. 2008 Jan;42(1):226–8.
Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis). Nefrologia. 2008;28 Suppl 3:67–78. In Spanish.
Reactivation of tuberculosis and vitamin D deficiency: the contribution of diet and exposure to sunlight. Thorax. 2007 Nov;62(11):1003–7.
Vitamin D and its implications for musculoskeletal health in women: An update. Maturitas. 2007 Oct 20;58(2):117–37. Review.
Vitamin D-deficiency rickets among children in Canada. CMAJ. 2007 Jul 17;177(2):161–6.
Expanding role for vitamin D in chronic kidney disease: importance of blood 25-OH-D levels and extra-renal 1alpha-hydroxylase in the classical and nonclassical actions of 1alpha,25-dihydroxyvitamin D(3). Semin Dial. 2007 Jul;20(4):316–324.
Prevalence of 25(OH) vitamin D insufficiency and deficiency in chronic kidney disease stage 5 patients on hemodialysis. Hemodial Int. 2007 Jul;11(3):315–21.
Identification and functional characterization of a novel mutation in the calcium-sensing receptor gene in familial hypocalciuric hypercalcemia: modulation of clinical severity by vitamin D status. J Clin Endocrinol Metab. 2007 Jul;92(7):2616–23.
Vitamin d and rehabilitation: improving functional outcomes. Nutr Clin Pract. 2007 Jun;22(3):297–304. Review.
Asymptomatic rickets in adolescent girls. Indian J Pediatr. 2007 Jun;74(6):571–5.
Calcium Plus Vitamin D Supplementation and the Risk of Postmenopausal Weight Gain. Arch Intern Med. 2007 May 14;167:893-902.
Effect of 2-Methylene-19-nor-(20S)-1alpha-Hydroxy- Bishomopregnacalciferol (2MbisP), an Analog of Vitamin D, on Secondary Hyperparathyroidism. J Bone Miner Res. 2007 May;22(5):686–94.
Prevalence of vitamin D deficiency rickets in adolescent school girls in Western region, Saudi Arabia. Saudi Med J. 2007 Mar;28(3):441–4.
Drug insight: vitamin D analogs in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease. Nat Clin Pract Endocrinol Metab. 2007 Feb;3(2):134–44. Review.
In vivo effects of chronic contamination with depleted uranium on vitamin D(3) metabolism in rat. Biochim Biophys Acta. 2007 Feb;1770(2):266–72.
Vitamin D and vascular calcification. Curr Opin Lipidol. 2007 Feb;18(1):41–6.
1,25-Dihydroxyvitamin D(3) regulates genes responsible for detoxification in intestine. Toxicol Appl Pharmacol. 2007 Jan 1;218(1):37–44.
Osteomalacia and secondary hyperparathyroidism after kidney transplantation: Relationship to vitamin D deficiency. Am J Med Sci. 2007 Jan;333(1):58–62.
Nutritional vitamin D deficiency presenting as hemichorea. J Child Neurol. 2007 Jan;22(1):74–6.
Cross-sectional analysis of abnormalities of mineral homeostasis, vitamin D and parathyroid hormone in a cohort of pre-dialysis patients. The chronic renal impairment in Birmingham (CRIB) study. Nephron Clin Pract. 2007;107(3):c109–16.
Effects of parathyroidectomy on bone remodeling markers and vitamin D status in patients with chronic kidney disease-mineral and bone disorder. Int Urol Nephrol. 2007;39(4):1251–6.
Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease. Am J Nephrol. 2007;27(1):36–43.
Severe vitamin D deficiency in chronic renal failure patients on peritoneal dialysis. Clin Nephrol. 2006 Oct;66(4):247–55.
Renal tubular acidosis type 2 with Fanconi's syndrome, osteomalacia, osteoporosis, and secondary hyperaldosteronism in an adult consequent to vitamin D and calcium deficiency: effect of vitamin D and calcium citrate therapy. Endocr Pract. 2006 Sep–Oct;12(5):559–67.
Antiepileptic drugs and bone metabolism. Nutr Metab (Lond). 2006 Sep 6;3(1):36.
Chronic contamination with 137Cesium affects Vitamin D3 metabolism in rats. Toxicology. 2006 Aug 1;225(1):75–80.
Osteoporotic fractures and vitamin D deficiency. Aust Fam Physician. 2006 Jul;35(7):519–20, 522.
Role of phosphorus and vitamin D analogs in the pathogenesis of vascular calcification. J Pharmacol Exp Ther. 2006 Jul;318(1):90–8.
Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation. Kidney Int. 2006 Jan;69(1):33–43. Review.
Vitamin D and its analogues: do they protect against cardiovascular disease in patients with kidney disease? Kidney Int. 2005 Nov;68(5):1973–81. Review.
25-hydroxyvitamin D levels and bone histomorphometry in hemodialysis renal osteodystrophy. Kidney Int. 2005 Oct;68(4):1840–8.
The role of vitamin D in vascular calcification in chronic kidney disease. Semin Dial. 2005 Jul–Aug;18(4):307–14. Review.
Vitamin D for health and in chronic kidney disease. Semin Dial. 2005 Jul–Aug;18(4):266–75. Review.
Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States. Am J Kidney Dis. 2005 Jun;45(6):1026–33.
Calcium and 1 alpha,25-dihydroxyvitamin D3 target the TNF-alpha pathway to suppress experimental inflammatory bowel disease. Eur J Immunol. 2005 Jan;35(1):217–24.
High ratio of 1,25-dihydroxyvitamin D3 to parathyroid hormone in serum of tuberculous patients with end-stage renal disease. Clin Nephrol. 2004 Sep;62(3):202–7.
Disturbances of calcium-PTH-vitamin D axis in chronic liver diseases. Arq Bras Endocrinol Metabol. 2004 Aug;48(4):443–50. Review.
1alpha,25-dihydroxyvitamin D3 inducible transcription factor and its role in the vitamin D action. Endocr Regul. 2004 Mar;38(1):29–38. Review.
Altered gene expression profile in the kidney of vitamin D receptor knockout mice. J Cell Biochem. 2003 Jul 1;89(4):709–19.
Short-term calcitriol administration improves calcium homeostasis in adults with cystic fibrosis. Osteoporos Int. 2003 Jun;14(5):442–9.
Renal failure and vitamin D. Clin Calcium. 2002 Jun;12(6):711–23.
Micronutrient accumulation and depletion in schizophrenia, epilepsy, autism and Parkinson's disease? Med Hypotheses. 2001 May;56(5):641–5.
Disorders of bone metabolism in gastrointestinal and hepatic diseases. Ned Tijdschr Geneeskd. 2000 Mar 4;144(10):462–7. Review.
A medical hypothesis: phosphorus balance and prostate cancer. Cancer Invest. 2000;18(7):664–9. Review.
Management of disturbed calcium metabolism in uraemic patients: 1. Use of vitamin D metabolites. Nephrol Dial Transplant. 2000;15 Suppl 5:18–24.
Regulation of renal calbindin-D28K. Pharmacol Toxicol. 2000;87 Suppl 3:5–30. Review.
Liver granulomatosis is not an exceptional cause of hypercalcemia with hypoparathyroidism in dialysis patients. J Nephrol. 1999 Nov–Dec;12(6):398–403.
Vitamin D analogs: perspectives for treatment. Miner Electrolyte Metab. 1999 Jul–Dec;25(4–6):337–41. Review.
Phosphorus balance and prostate cancer. Indian J Exp Biol. 1999 Jul;37(7):623–6. Review.
Altered calcium homeostasis in adults with cystic fibrosis. Osteoporos Int. 1999;10(2):102–8.
Saccharated ferric oxide (SFO)-induced osteomalacia: in vitro inhibition by SFO of bone formation and 1,25-dihydroxy-vitamin D production in renal tubules. Bone. 1997 Jul;21(1):57–64.
Effect of aging on the metabolism of phosphorus and 1,25-dihydroxyvitamin D in healthy men. Am J Physiol. 1996 Mar;270(3 Pt 1):E483–90.
Vitamin D deficiency in veterans with chronic spinal cord injury. Metabolism. 1995 Dec;44(12):1612–6.
Metabolic bone disease in gastrointestinal, hepatobiliary, and pancreatic disorders and total parenteral nutrition. Curr Opin Rheumatol. 1995 May;7(3):249–54. Review.
1,25(OH)2-16ene-vitamin D3 is a potent antileukemic agent with low potential to cause hypercalcemia. Leuk Res. 1994 Jun;18(6):453–63.
Metabolic bone disease in black teenagers with genu valgum or varum without radiologic rickets: a bone histomorphometric study. J Bone Miner Res. 1994 Apr;9(4):479–86.
Low serum vitamin D metabolites in women with rheumatoid arthritis. Scand J Rheumatol. 1993;22(4):172–7.
Influence of cadmium on the metabolism of vitamin D3 in rats. Toxicol Appl Pharmacol. 1987 Jun 30;89(2):158–64.
Main endocrine modulators of vitamin D hydroxylases in human pathophysiology. J Steroid Biochem. 1987;27(4–6):815–24. Review.
Vitamin D metabolites in idiopathic infantile hypercalcaemia. Arch Dis Child. 1985 Dec;60(12):1140–3.
Low serum concentrations of 1,25-dihydroxyvitamin D in human magnesium deficiency. J Clin Endocrinol Metab. 1985 Nov;61(5):933–40.
Magnesium administration reverses the hypocalcaemia secondary to hypomagnesaemia despite low circulating levels of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D. Clin Endocrinol (Oxf). 1985 Jun;22(6):807–15.
Low serum 25-hydroxyvitamin D in hereditary hemochromatosis: relation to iron status. Gastroenterology. 1985 Apr;88(4):865–9.
A case of hypoparathyroidism in a child with beta-thalassemia successfully treated with 1 alpha-hydroxy-vitamin D3. Helv Paediatr Acta. 1981;36(2):171–3.
Serum vitamin D and related mineral metabolism in cystic fibrosis. Nutr Rev. 1979 Aug;37(8):247–9.
Case report: hypoparathyroidism and iron storage disease. Treatment with 25-hydroxyvitamin D3. Am J Med Sci. 1978 Nov–Dec;276(3):363–8.
Vitamin D: the discovery of its metabolites and their therapeutic applications. Pediatrics. 1976 May;57(5):729–41. Review.
Metabolism and action of the hormone vitamin D. Its relation to diseases of calcium homeostasis. West J Med. 1974 Jul;121(1):22–44. Review.
Calcium absorption in health and disease. II. Syndromes of imparied calcium absorption (author's transl). Klin Wochenschr. 1974 Jan 15;52(2):64–73. Review.
Vitamin D metabolism and its relationship to familial hypophosphatemia. Birth Defects Orig Artic Ser. 1970 Sep;6(3):26–7.
Role of hormones in magnesium metabolism. Sem Hop. 1969 Jun 8;45(27):1895–900. Review.

back to research menu

*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Unless otherwise expressly stated, all site content licensed under a Creative Commons License.